1 Compared with
identically treated 108 historical controls without Treg
2 red with pretransplant CD8 T cells that were
identically treated by a one-time activation and rest in
3 esponse was induced that was not observed in
identically treated CD40 knockout mice.
4 tumor necrosis factor alpha levels than did
identically treated cells from unaffected persons (P=0.0
5 to homogenate was investigated by subjecting
identically treated control and electrically-treated sam
6 Animals were randomized to
identically treated controls in which the aorta was not
7 leads to significantly more MN loss than in
identically treated controls.
8 uring ischemia in the FCCP-treated hearts to
identically treated FCCP-free hearts.
9 rk of shorter actin filaments in lamellae of
identically treated FLNa-expressing cells capable of tra
10 The outcomes were compared with 22
identically treated historical patients who received all
11 cells within the airway epithelium than did
identically treated +/+
mice.
12 ly lost several weeks following TBI, whereas
identically treated naive mice at the same time point ha
13 These tangles, which are not detected in
identically treated normal tau or AD P-tau alone, are ma
14 Twenty comparable, concurrently and
identically treated patients (who were eligible and woul
15 ures of gingival MOs remained viable whereas
identically treated peripheral blood MN/MOs rapidly lost
16 he metallothionein IIa gene were detected in
identically treated primary human lens epithelial cells.
17 n, while no limb defects are observed in the
identically treated SWV strain.
18 cells within the airway epithelium than did
identically treated WBB6F(1)-+/+ normal mice.
19 flammation and reactivity, and compared with
identically treated wild-type (WT) control mice.
20 mice was approximately 35% less than that in
identically treated wild-type mice (P < 0.01).
21 d more rapid hematopoietic recovery than did
identically-treated wild-type mice.
22 s than 50% of the granulocytosis observed in
identically treated WT mice.
23 en contents to levels comparable to those in
identically treated WT.